Zacks Investment Research: Zacks Media Conglomerates industry players like SPHR, LION and MSGE gain from the rising demand for high-speed Internet and increased media consumption.

Zacks Investment Research: Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Reuters: Archer Aviation said on Wednesday it had partnered with Serbia as the country's preferred electric vertical take-off and landing aircraft partner, in a move to expand into global markets.

The Motley Fool: Bank of America analyst Dimple Gosai upgraded Oklo stock to buy this morning. Gosai cited the nuclear stock's power presale agreement with Meta as a key vote of confidence.

Zacks Investment Research: DraftKings (DKNG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Schwab Network: Johnson & Johnson (JNJ) posted better-than-expected earnings but still traded to the downside. Diane King Hall points to Stelara as the cause.

Business Wire: LOS ANGELES--(BUSINESS WIRE)-- #1org--1.org, the free charitable search engine from System1 (NYSE: SST), today announced a partnership with Guide Dogs of America | Tender Loving Canines (GDA | TLC) to direct a percentage of its search-driven advertising revenue toward the training and placement of guide and service dogs. In other words: your everyday web searches can now help more people get matched with a life-changing guide or service dog. With 1.org, users can select GDA | TLC as their cause and sup.

GlobeNewsWire: Bridgepointe's network of expert tech advisors – trusted by over 12,000 companies – will accelerate the adoption and implementation of SoundHound's AI agent platform, Amelia 7, and Autonomics solution Bridgepointe's network of expert tech advisors – trusted by over 12,000 companies – will accelerate the adoption and implementation of SoundHound's AI agent platform, Amelia 7, and Autonomics solution

Business Wire: PITTSBURGH--(BUSINESS WIRE)---- $AUR #aurora--Aurora Innovation, Inc. (NASDAQ: AUR) today announced it will release fourth quarter 2025 results after market close on February 11, 2026 and will host a business review conference call that day at 5:00 p.m. Eastern time. The conference call will be webcast on Aurora's investor relations website at ir.aurora.tech. A replay of the webcast will be available for 30 days following the call. About Aurora Aurora (Nasdaq: AUR) is delivering the benefits of self-driving tec.

Benzinga: As of Jan. 21, 2026, two stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Bloomberg Technology: Mark Douglas, MNTN CEO, says Warner Bros. has a well established advertising business, while Netflix is still building its ad platform.

Business Wire: LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today released its first annual Baby Sleep Report, a review of sleep data gathered from over the 1.2 million babies monitored by Owlet products in 2025. The global report analyzes nearly 900 million hours of monitored infant sleep from babies across 200 geographic regions, offering new insight into sleep patterns, trends, and development – providing parents with data-informe.

24/7 Wall Street: We're halfway into January, and the market is in action mode. Growth stocks have had an excellent 2025 and generated impressive returns for investors.

Accesswire: - Single Phase 2/3 Adaptive Study Design - - Clinically Relevant, Objective Composite Endpoint - SAN DIEGO, CA / ACCESS Newswire / January 21, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, announced that the Company has reached agreement with the FDA on an approval pathway for Gemini as a treatment for Acute Kidney Injury (AKI). The two key agreements were 1) a clinically relevant and objective composite endpoint comprising death and/or need for dialysis, and 2) positive data from a single well-controlled Phase 2/3 adaptive design clinical study, comprising approximately 300 patients, would be sufficient for submission of a new drug application (NDA).

Investors Business Daily: Nuclear startup Oklo enters Wednesday up more than 25% in 2026.

GlobeNewsWire: Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare

GlobeNewsWire: PROVO, Utah, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Angel (NYSE: ANGX) (the “Company”), a media and technology company guided by two million grassroots Angel Guild members championing values-driven stories, today announced its participation in the following upcoming investor conferences during the first quarter of 2026. The 11th Annual Oppenheimer Emerging Growth Conference, taking place virtually, February 3 – 4, 2026.

The Motley Fool: QuantumScape (QS 3.03%) is nearing a pivotal moment as solid-state battery testing moves into real vehicles in 2026. This video breaks down the catalysts, risks, and why success could unlock massive upside while failure could reset expectations fast.

Business Wire: LONDON & NEW YORK--(BUSINESS WIRE)--Vertical Aerospace (NYSE: EVTL) launches its U.S. tour in New York City this week, bringing its new commercial electric aircraft, Valo, to the U.S. for the first time alongside plans for electric air travel routes in New York with Bristow Group (NYSE: VTOL) and Skyports Infrastructure. The U.S. tour builds on Valo's unveiling in London in December 2025 and marks the next step in Vertical's global engagement with customers, investors, regulators, and partners.

The Motley Fool: SoundHound AI stock has pulled back in recent months, but its growth remains outstanding. The company could easily outpace Wall Street's growth expectations in 2026.